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RESUM 
Les llàgrimes artificials lipídiques són un tipus de suplements lacrimals formats per lípids, entre 
d’altres components, amb la finalitat de restaurar la capa lipídica fisiològica de la pel·lícula 
lacrimal. La capa lipídica s’encarrega de disminuir l’evaporació de la llàgrima, a més de lubricar 
en el parpelleig, per aquest motiu les llàgrimes lipídiques estan indicades, especialment, en 
pacients amb ull sec per excessiva taxa d’evaporació de la pel·lícula lacrimal. Un dels 
components lipídics que s’utilitzen en aquest tipus de llàgrimes artificials és la lecitina de soja. 
En el present estudi s’han analitzat les propietats fisicoquímiques de tres llàgrimes artificials 
comercials basades en aquest component, la Zero, l’Optrex i l’Opticalm en format esprai. S’han 
obtingut les isotermes àrea-pressió superficial i s’ha intentat corroborar l’efectivitat d’aquestes 
tècniques per estudiar el comportament dels components lipídics de les llàgrimes i extreure 
conclusions sobre algunes de les seves propietats. A més s’ha complementat el treball amb un 
estudi clínic amb la finalitat d’intentar establir algun tipus de relació entre els resultats 
fisicoquímics i els resultats clínics. 
S’ha vist que l’Opticalm és la llàgrima amb més fluïdesa de les tres estudiades i que l’Opticalm 
en comparació amb l’Oprex produeix més millora en els resultats de les proves de qualitat de la 
llàgrima, la qual cosa podria estar relacionada amb la seva major fluïdesa constatada en la primera 
part de l’estudi. 
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RESUMEN 
Las lágrimas artificiales lipídicas son un tipo de suplementos lagrimales formados por lípidos, 
entre otros componentes, con la finalidad de restaurar la capa lipídica fisiológica de la película 
lagrimal. La capa lipídica se encarga de disminuir la evaporación de la lágrima, además de 
lubricar en el parpadeo, por este motivo las lágrimas lipídicas están indicadas, especialmente, en 
pacientes con ojo seco por excesiva tasa de evaporación de la película lagrimal. Uno de los 
componentes lipídicos que se utilizan en este tipo de lágrimas artificiales es la lecitina de soja. 
En el presente estudio se han analizado las propiedades fisicoquímicas de tres lágrimas 
artificiales comerciales basadas en este componente, la Zero, la Optrex y la Opticalm en formato 
esprai. Se han obtenido las isotermas área-presión superficial y se ha intentado corroborar la 
efectividad de estas técnicas para estudiar el comportamiento de los componentes lipídicos de 
lágrimas i extraer conclusiones sobre algunas de sus propiedades. Además se ha complementado 
el trabajo con un estudio clínico con la finalidad de intentar establecer algún tipo de relación 
entre los resultados fisicoquímicos i los resultados clínicos. 
Se ha visto que la Opticalm es la lágrima con más fluidez de las tres estudiadas y que la Opticalm 
en comparación con la Optrex produce más mejora en los resultados de las pruebas de cualidad 
de la lágrima, la cual cosa podría estar relacionada con su mayor fluidez constatada en la primera 
parte del estudio. 
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ABSTRACT 
Lipid artificial tears are a sort of tear supplement formed by lipids and some other components 
that have the goal of restoring the physiological lipid layer of the tear film. The lipid layer 
function is to diminish the evaporation of the tear and to lubricate the eye during blinking. For 
this reason lipid tears are especially indicated for dry-eye patients whose rate of tear film 
evaporation is excessive. One of the lipid components used in this type of artificial tears is soy 
lecithin. In the present study, the physical and chemical properties of three commercial artificial 
tears based on soy lecithin have been analyzed. These include Zero, Optrex and Opticalm in 
spray format. Surface pressure-area isotherms have been obtained and the effectiveness of these 
techniques has been tested in order to study the behaviour of the lipid components of the tears 
and work out conclusions on some of their properties. Furthermore, the work has been 
complemented with a clinical study that had the goal of determining if there was any relationship 
between the physical and chemical tests and the clinical results. 
In the tests, Opticalm was the tear that showed the greatest fluidity of the three tears under study 
and when compared to Optrex, Opticalm yields greater improvement in the results of the tests of 
tear quality, which could be related to its greater fluidity verified in the first part of the study. 
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COVER LETTER 
 
Dear Editor, Prof. JL Brash, 
 
I hereby send you the article "Lipid-containing artificial tear. A study on physicochemical 
properties and clinical results" which authors are Àlex Julien Jolis, Carme Serés Reves and Joan 
Torrent Burgués for its publication in Colloids and Surfaces B: Biointerfaces. 
The article has two parts; the first one is the physicochemical part that deals with the study of three 
lipid-containing commercial tears using the technique of Langmuir. Lipids of these tears spread 
over the air-water interface and they can be studied registering the surface pressure-area isotherms. 
The present study shows that the technique of Langmuir can be useful to analyze the properties of 
the surface of these tears such as fluidity and extension in conditions that are similar to when they 
are applied to the eye. The second part of this article is a small clinical study of two of the studied 
tears with a small sample of patients, in order to observe if any improvement is observed in the 
results of some tests on tear quality and quantity. In spite that the clinical study is in a very early 
stage and must be carried out with a larger sample, a relationship has been established between the 
results obtained in the two parts of the study (clinical part and physicochemical part). 
The authors hope that this subject will be of interest for the readers of the publication. Some 
references published in COLSUB that deal with artificial lipid-containing tears are quoted in the 
article. As far as the authors know, this is the first time that a study is undertaken comparing a 
physicochemical study with a clinical study, hence the interest of its publication. These tears are 
sold in pharmacies and optician's shops and, according to the authors' opinion, there is a lack of 
knowledge about the properties and behaviour of those products. 
 
Sincerely 
 
Àlex Julien Jolis 
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Highlights 
 
Lipid-containing artificial tears are a type of tears which main component are lipids. Their main 
function is that of restoring the physiological lipid layer of the tear film and so avoiding its 
evaporation. 
 
The formation of a Langmuir monolayer is achieved by laying molecules with an amphiphilic 
structure (polar head and non-polar tail) on the water-air interface. The head will orientate towards 
the water and the tail towards the air in a manner that a monolayer will be formed. This is a useful 
technique to study the eye tear since it simulates the physiological lipid layer of the tear. 
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Opticalm is the tear that shows the greatest compressibility and the greatest fluidity of the three 
tears under study. This is believed to achieve a better spreading over the tear film and that this is the 
reason why Opticalm seems to yield the best results in the clinical part. 
 
Neither the present study nor those undertaken in the past demonstrate that lipid-containing 
artificial tears yield a real effect in the properties of the tears of the users. 
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SUMMARY  
 
Lipid artificial tears are a sort of tear supplement formed by lipids and some other components that 
have the goal of restoring the physiological lipid layer of the tear film. The lipid layer function is to 
diminish the evaporation of the tear and to lubricate the eye during blinking. For this reason, lipid 
tears are especially indicated for dry-eye patients whose rate of tear film evaporation is excessive. 
One of the lipid components used in this type of artificial tears is soy lecithin. In the present study, 
the physical and chemical properties of three commercial artificial tears based on soy lecithin have 
been analyzed. These include Zero, Optrex and Opticalm in spray format. Surface pressure-area 
isotherms have been obtained and the effectiveness of these techniques has been tested in order to 
study the behaviour of the lipid components of the tears and work out conclusions on some of their 
properties. Furthermore, the work has been complemented with a clinical study that had the goal of 
determining if there was any relationship between the physical and chemical tests and the clinical 
results. 
In the tests, Opticalm was the tear that showed the greatest fluidity of the three tears under study 
and when compared to Optrex, Opticalm yields greater improvement in the results of the tests of 
tear quality, which could be related to its greater fluidity verified in the first part of the study. 
  
1. Introduction 
 
The use of artificial tears basically is recommended for people with symptoms of eye dryness [1,2]. 
Some studies have been undertaken on lipid-containing artificial tears on drops [1,2-4], but few are 
available on lipid preparations on spray [5, 6, 7]. The main lipid component of these tears is soy 
lecithin, which is basically formed by phosphatidylcholine (PC), although some other lipid kinds 
can be found. 
The Langmuir technique has been used by other authors to study the behaviour of lipids secreted by 
Meibomian glands [8-12] and particularly to study their interaction with tear proteins [13-16]. This 
technique has also been used to study the behaviour of the lipids in commercial lipid-containing 
artificial tears [5] like the present case. In this study, three commercial brands have been studied 
including Zero (never studied before by any author), Optrex and Optical (in order to confirm the 
results obtained in other studies [5]). BUT, NIBUT and tear meniscus height were mesured before 
and after instilling Optrex and Opticalm tears. The BUT (Breakup Time) and the NIBUT (Non-
Invasive Breakup Time) are two methods to measure the time of tear breakup, i.e. the time it takes 
for the tear to breakup without blinking. BUT instills fluorescein and NIBUT does not. The tear 
meniscus height has also been measured (a test of tear volume) before and after the instillation of 
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artificial tears. No other works have been found studying the correlation between the 
physicochemical behavior and the clinical behaviour of lipid-containing artificial tears. 
  
2. Materials and methods 
 
Physicochemical part 
 
2.1. Materials 
 
The lipid-containing artificial tears under study are Zero (Manufacturer: Optima Medical Swiss AG, 
Distributor: DISOP), Optrex (Manufacturer: Optima Medical Swiss AG, Distributor: Reckitt 
Benckiser Healthcare)  and Opticalm (Manufacturer: Medena AG, Distributor: Omega Pharma). 
Their compositions are detailed below (Table 1). As it can be seen, Zero and Optrex have exactly 
the same components and the only difference between them is that Zero does not specify their 
concentration. Opticalm, in opposition to the other two brands, does not contain phenoxyethanol 
and has a lower concentration of sodium chloride than Optrex. 
 
Table 1 
Composition of the lipid-containing artificial tears of the study in 1 ml. 
 
Composition in 1ml Zero Optrex Opticalm 
Soy lecithin * 10 mg 10 mg 
Sodium chloride * 8 mg 2.8 mg 
Ethanol * 8 mg 8 mg 
Phenoxyethanol * 5 mg - 
Vitamin A * 0.25 mg 0.25 mg 
Vitamin E * 0.02 mg 0.02 mg 
 
*Contains the component but concentration is not specified 
Surface pressure-area isotherms have also been taken and studied of the POPC 
(palmitoyloleoylphosphatidylcholine), DPPC (dipalmitoylphosphatidylcholine) and DDHA-PC 
(didocosahexenoylphosphatidylcholine), being all three type PC phospholipids. 
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 2.2 Methods 
 
To measure surface pressure-area isotherms a NIMA teflon trough, model 1232D1D2 (1200 cm2) 
with two movable barriers was used and a Wilhelmy plate was been used to measure surface 
pressure. A linear velocity with barriers of 50 cm2/min was used and the volume used in each 
isotherm was 30 µl. This procedure was carried out at 23ºC (room temperature of the laboratory). 
The trough and the teflon barriers were cleaned with chloroform and distilled water after each 
measure. 
Since the instilled volume with this kind of spray diffuser cannot be controlled with precision, a 
micro-syringe was used in the experiments. The tear was instilled drop by drop distributed onto the 
trough and it was left to settle during 15 minutes (the necessary time considered to allow for the 
extension of the lipids). After this period, compression was initiated by closing the barriers at the 
mentioned speed until the collapse point was reached. 
 
 
Clinical part 
 
2.3 Statistical analysis 
 
For the statistical analysis of the results in the clinical part, the program IBM SPSS Statistics was 
used. With the objective of analyzing if there are significant differences between the results 
obtained before and after the instillation of the tear, it was first studied if these data groups followed 
a normal distribution. Shapiro Wilks was used since the sample is < 50 and a normal distribution 
was considered if a p > 0.05 was achieved. Afterwards, if both data groups (pre and post) followed 
a normal distribution Repeated mesures ANOVA test was used and if one or both data groups did 
not follow a normal distribution Friedman test was used. Differences were considered statistically 
significant when p < 0.05. 
To know if there were statistically significant differences between the increases elicited by Optrex 
and Opticalm in the tests, the same procedure was followed. 
 
2.4 Materials 
 
The clinical study used a sample of 16 people, 8 males and 8 females of an age range between 19 
and 70 years old. Optrex and Opticalm artificial tears were studied, which composition is detailed in 
Table 1.  
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In order to measure the tear meniscus height a biomicroscope Topcon SI-D701 and an eyepiece 
with 0.1 mm resolution was used. The NIBUT was measured with the topographer OCULUS 
Easygraph Type 70620 and for the BUT fluorescein strips BioGlo Fluorescein Sodium Ophtalmic 
U.S.P., saline solution Hidro Health NaCl of DISOP (Composition: Sodium chloride, boric acid, 
sodium tetraborate, and disodium edetate at 0.05% and polyhexametilene biguanide at 0.0002% in 
purified water) and a F-Scope hand lamp for better visualization of the tear breakup. 
 
2.5 Methods 
 
Tear meniscus height, NIBUT and BUT tests were carried out (in this order) before and after 
instilling Optrex in one eye and Opticalm in the other eye randomly in each patient. Only these two 
tears were analyzed for two reasons, firstly to ease the procedure (it is easier to randomly choose 
one of the 2 eyes) and secondly because the concentrations of Zero are not known. Tears were 
instilled 45 minutes after the BUT to ensure the disappearance of any sodium fluorescein. The 
instillation was carried out following the instructions of use of the manufacturer, one single spray 
shot with the eye closed at a distance of 10 cm. After the instillation of the tear, 3 minutes were 
waited before repeating the tests. The tear breakup time was considered to be that from the last 
blinking of the patient up to the distortion in any point of the rings of the topographer (NIBUT) or 
up to observation of a dark spot in any point of the cornea (BUT). The BUT was measured by 
placing one drop of saline solution and making a single touch on the upper bulbar conjunctiva of the 
patient. 
 
 
3. Results and discussion 
 
Physicochemical part 
 
In Fig. 1A, the isotherms obtained with 30 µl of the tears Optrex (a), Zero (b) and Opticalm (c) over 
a sub-phase of water at 23ºC can be seen. In order to obtain a better comparison, in the X axis the 
area was transformed in area per molecule, taking the concentration prescribed by the manufacturer 
and considering that the lipid present in these tears is POPC, since PC (phosphatidylcholine) is one 
of the main lipids that is formed by soy lecithin, as explained in the introduction. There are other 
components with tensioactive characteristics in the composition of the tears but in a very low 
concentration that could not alter significantly the values of area per molecule. 
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The isotherms of Optrex and Zero tears are almost the same and are not very apart one of each 
other, therefore we can conclude that the concentrations of the latter (not specified by the 
manufacturer) are similar to those of Optrex. Fig. 1A shows that the initial surface pressure of 
Optrex is 0 and that of Zero is very close to 0, which but, on the contrary, Opticalm starts above 15 
mN/m. It can also be seen that the isotherm that starts to go up first,  although in a smoother way 
than the other ones is that of Opticalm, followed by Zero and finally Optrex. If the area value per 
molecule in the collapse point is observed in the isotherms of Optrex, Zero and Opticalm, it can be 
inferred that a perfect monolayer was not formed, since if it had been formed the collapse area 
should be ≈50 Å2/molecule (the area of a POPC molecule). On the contrary, the areas found were 
≈7 Å2/molecule (Optrex), ≈20 Å2/molecule (Zero) and ≈25 Å2/molecule (Opticalm), indicating the 
existence of a bilayer or even more. Since lipids present in the artificial tear are in the form of 
liposomes (one bilayer or two or more), this seems to indicate that they remain in the form of 
extended bilayer or even as two bilayer in the case of Optrex (but a more accurate analysis of the 
areas can't be done since they strongly depend on the concentration and the volume spread, which 
always have an error range). As far as the concentration is concerned, it is specified in the 
commercial product and hence it can be approximate, not exact. In the case of Zero it is not 
specified  and we have assumed a concentration equal to that of the other two tears. The value of 
area per molecule is also influenced by the lipid's molecular mass and we have taken just one lipid, 
the POPC, as a reference but the exact composition of each tear is unknown. 
The isotherms were obtained at a temperature of 32ºC and it was observed that the point of collapse 
takes place at a surface pressure slightly lower than when they are taken at room temperature (23ºC) 
but apart from this completely foreseeable fact, no significant differences were observed. 
Fig. 1B shows the inverse of the compressibility module of the isotherms in Fig. 1A. Also, a very 
different behaviour in Opticalm (c) is observed, since it shows much lower Cs-1 values than those of 
the other two tears. This indicates that PCs present in the composition of Opticalm are more likely 
to have more unsaturations and hence a greater fluidity than the other two tears. This also fits the 
behaviour of the isotherms because if Opticalm has lipids with greater fluidity, they can spread 
better in a monolayer. In spite of this, the three tears show quite low Cs-1 values which means that 
all of them have certain fluidity. 
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Fig. 1. (A) Surface pressure-area isotherms in the three lipid-containing artificial tears: (a) Optrex, (b) Zero, 
(c) Opticalm. (B) Inverse of the compressibility module isotherms of Fig. 1.A. 
 
In Table 2 the parameters that define the isotherms obtained at 23ºC can be seen for each of the 
artificial tears under study and for three different phospholipids. If we look at the Π collapse values, 
it can be seen that tear values are more similar to those of the unsaturated phospholipids, such as 
POPC and DDHA-PC, than those of the saturated phospholipid DPPC are. 
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Table 2 
Characteristical parameters of the isotherms of the three lipid-containing artificial tears and other 
phospholipids of the PC family. 
 
 
 
Clinical part 
 
In Table 3 the means and standard deviation of the results of the tear meniscus height, NIBUT and 
BUT can be seen, before instilling of lipid-containing tears (Pre) and after (Post), for tears Optrex 
(Table 3A) and Opticalm (Table 3B). In Annex A all values that were obtained are shown. 
 
Table 3 
Results of the tear meniscus height test, NIBUT and BUT, pre and post Optrex (A) and Opticalm (B) 
instillation. 
 
 (A) 
 OPTREX 
Pre Post 
A. Meniscus 
(mm) NIBUT (s) BUT (s) 
A. Meniscus 
(mm) NIBUT (s) BUT (s) 
Mean 0.169 8.562 5.937 0.184 9.437 6.375 
St. Dev. 0.057 2.707 1.482 0.051 2.502 1.996 
 
  
 
 
 
 
Tear of  PC A lift-off (A2/molecule) A collapse (A2/molecule) ∏ collapse (mN/m) Cs-1 max (mN/m) Reference 
ZERO > 43 20 45 103 This work 
OPTREX 25 7 47 65 This work 
OPTICALM > 100 25 42 31 This work 
POPC 95 46 49 15 This work 
DDHA PC 107 47 42 89 This work 
DPPC 93 40 60 253 This work 
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(B) 
 OPTICALM 
Pre Post 
A. Meniscus 
(mm) NIBUT (s) BUT (s) 
A. Meniscus 
(mm) NIBUT (s) BUT (s) 
Mean 0.169 9.062 5.562 0.181 10.062 6.937 
St. Dev. 0.057 2.744 1.504 0.048 2.594 1.692 
 
 
In Table 3, it can be easily seen that the means of the results obtained after instilling any of the tears 
are all larger than those obtained before instillation. However, these increases need to be 
statistically checked for significance for each of the categories. 
In Fig. 2 the comparison of the pre and post values of the meniscus height (Fig. 2A), NIBUT (Fig. 
2B) and BUT (Fig. 2C) can be seen for both studied tears in the clinical part. The graphs that 
compare meniscus height and NIBUT (Fig. 2A and Fig. 2B) show that the mean post in both tests 
and for both tears is larger than that of the mean pre, with the exception of NIBUT of Optrex, which 
show the same value. As far as the tear meniscus height is concerned, the Optrex and Opticalm 
graphs are exactly the same. This measure always gave exactly the same value in the right eye and 
in the left eye in a given patient, i.e. the pre values were always the same in both eyes and when 
they increased in the post values they did it also in both eyes. 
 
 
   
 
 
 
(A) (B) 
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Fig. 2. Comparison of pre and post tear meniscus height (A), NIBUT pre and post (B) and BUT pre and post 
(C) for Optrex and Opticalm. 
 
Fig. 3 shows the comparison between the increases of tear meniscus height (Fig. 3A), NIBUT (Fig. 
3B) and BUT (Fig. 3C) for Optrex and Opticalm. 
 
 
 
       
 
 
 
 
 
 
 
(C) 
(A) (B) 
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Fig. 3. Comparison between the increase of tear meniscus height (A), NIBUT (B) and BUT (C) for Optrex 
and Opticalm.  
 
In order to analyze if there are significant differences between the pre and post results of each of the 
tests, we have first checked that all data groups follow a normal distribution; this was true for all 
data groups except in the case of the post tear meniscus height of Opticalm and pre and post BUT of 
Optrex. 
The tear meniscus height shows a statistically significant increase (Optrex p = 0.02 and Opticalm p 
= 0.046) between the pre and post values both for the Optrex and Opticalm tears. This could be a 
consequence that these tears diminish the tear evaporation rate and consequently the value 
increases. There are no significant differences (Optrex p = 0.1 and Opticalm p = 0.108) between the 
pre and post values of  NIBUT for neither tear although post values are slightly higher than pre 
values. The differences between the pre and post results of BUT for Optrex are not statistically 
significant (p = 0.166) but they are for Opticalm (p = 0.002). Therefore, Opticalm seems to elicit a 
greater improvement of BUT results but not Optrex. This difference was statistically tested, as 
follows. 
In order to compare both tears, significance tests were run between meniscus height, NIBUT and 
BUT increases for Optrex and Opticalm. Tear meniscus and NIBUT showed no statistically 
significant differences were observed between any of the tears (Tear meniscus height p = 0.317 and 
NIBUT p = 0.865). BUT increase elicited by Opticalm (Mean = 1.375s SD= 1.45) is not statistically 
higher (p = 0.055) than that of Optrex (Mean = 0.4375 s SD= 1.21). However, in the latter case the 
value of p is so close to 0,05 that suggests that Opticalm actually elicits a larger improvement than 
Optrex in BUT results. 
(C) 
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A lipid-containing artificial tear is expected to improve the quality of the tear but not its quantity 
but interestingly both tears show a greater increase in the tear volume test (Tear Meniscus height) 
than in NIBUT and BUT, suggesting that a larger sample for the clinical part in a future study 
would be very helpful to reach stronger conclusions. 
The fact that Opticalm produces a BUT increase greater than that of Optrex in the clinical part, 
could be related to the larger fluidity of Opticalm demonstrated in the physicochemical study. A 
larger fluidity of an artificial tear can mean a better spreading over the tear film and, consequently, 
a more positive effect in the results of the tear quality tests. 
Other works with larger samples, focused on the analysis of the effectiveness of lipid-containing 
artificial tears on spray have shown that there are no differences with the effect produced by the 
placebo [17], therefore it is not demonstrated that this sort of tears produce a real effect in tear 
properties. 
 
 
4. Conclusions 
 
The physicochemical part has demonstrated that Opticalm is the tear with greatest fluidity. Also, we 
have shown that Zero has a very similar behavior to that of Optrex and consequently we can infer 
that its concentrations (not given by the manufacturer) are also very similar. 
Since this is a preliminary study and the sample is small, no sound conclusions can be inferred from 
the clinical part. However, it has been seen that both tears under study elicit a statistically 
significant increase of the tear volume, a non-statistically significant increase in NIBUT and a non-
statistically significant increase in BUT for Optrex but statistically significant for Opticalm. The 
comparison of the increases caused by both tears shows that only Opticalm's BUT causes a slightly 
higher improvement than Optrex, being statistically significant at the 94% confidence level (p < 
0.06) instead of the usually established 95% (p < 0.05). 
The main relationship found between both parts of the study is that the greater fluidity of Opticalm 
could favour a better spreading of the artificial tear over the tear film, thus increasing BUT more 
than Optrex does. 
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Figure and table footnotes 
 
Table 1. Composition of the lipid-containing artificial tears of the study in 1 ml. 
Table 2. Characteristical parameters of the isotherms of the three lipid-containing artificial tears 
and other phospholipids of the PC family. 
Table 3. Results of the tear meniscus height test, NIBUT and BUT, pre and post Optrex (A) and 
Opticalm (B) instillation. 
Fig. 1. (A) Surface pressure-area isotherms in the three lipid-containing artificial tears: (a) Optrex, 
(b) Zero, (c) Opticalm. (B) Inverse of the compressibility module isotherms of Fig. 1.A. 
Fig. 2. Comparison of pre and post tear meniscus height (A), NIBUT pre and post (B) and BUT pre 
and post (C) for Optrex and Opticalm. 
Fig. 3. Comparison between the increase of tear meniscus height (A), NIBUT (B) and BUT (C) for 
Optrex and Opticalm.  
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APPENDIX A 
 
Full results of the tear meniscus height test, NIBUT and BUT, pre and post Optrex (A) and 
Opticalm (B) instillation. 
 
 
(A) 
OPTREX 
Pre Post 
A. Menisc (mm) NIBUT (s) BUT (s) A. Menisc (mm) NIBUT (s) BUT (s) 
0.15 9 5 0.2 6 4 
0.2 5 5 0.2 9 6 
0.3 8 7 0.3 8 6 
0.1 7 4 0.1 8 4 
0.15 9 8 0.15 12 6 
0.1 3 5 0.15 8 6 
0.1 7 5 0.15 7 4 
0.2 10 7 0.2 10 7 
0.15 9 6 0.15 10 6 
0.1 11 5 0.15 13 6 
0.2 8 5 0.25 6 6 
0.2 11 8 0.2 12 10 
0.25 14 8 0.25 14 10 
0.15 7 5 0.15 8 6 
0.2 12 8 0.2 12 10 
0.15 7 4 0.15 8 5 
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(B) 
OPTICALM 
Pre Post 
A. Menisc (mm) NIBUT (s) BUT (s) A. Menisc (mm) NIBUT (s) BUT (s) 
0.15 8 6 0.2 6 5 
0.2 6 5 0.2 12 6 
0.3 8 5 0.3 9 7 
0.1 5 3 0.1 7 6 
0.15 7 4 0.15 7 6 
0.1 10 5 0.15 9 6 
0.1 7 5 0.15 8 6 
0.2 9 6 0.2 10 6 
0.15 8 6 0.15 10 7 
0.1 15 5 0.15 15 9 
0.2 7 4 0.2 12 7 
0.2 10 7 0.2 12 10 
0.25 14 9 0.25 14 10 
0.15 9 6 0.15 12 8 
0.2 12 8 0.2 10 8 
0.15 10 5 0.15 8 4 
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results: Give some examples of results and analysis of the results which will give the reader an 
impression what to expect.  
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for review. Please check the relevant section in this Guide for Authors for more details.  
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• Full postal address  
All necessary files have been uploaded: 
Manuscript: 
• Include keywords 
• All figures (include relevant captions) 
• All tables (including titles, description, footnotes) 
• Ensure all figure and table citations in the text match the files provided • Indicate clearly if color 
should be used for any figures in print Graphical Abstracts / Highlights files (where applicable)  
Supplemental files (where applicable)  
Further considerations 
• Manuscript has been 'spell checked' and 'grammar checked' 
• All references mentioned in the Reference List are cited in the text, and vice versa 
• Permission has been obtained for use of copyrighted material from other sources (including the 
Internet) 
• Relevant declarations of interest have been made  
• Journal policies detailed in this guide have been reviewed 
• Referee suggestions and contact details provided, based on journal requirements  
For further information, visit our Support Center. BEFORE YOU BEGIN  
Ethics in publishing  
Please see our information pages on Ethics in publishing and Ethical guidelines for journal 
publication.  
Human and animal rights  
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finalized, please 'Save as' or convert the images to one of the following formats (note the resolution 
requirements for line drawings, halftones, and line/halftone combinations given below): 
EPS (or PDF): Vector drawings, embed all used fonts. 
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi. 
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 
dpi. TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a 
minimum of 500 dpi. 
Please do not: 
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have 
a low number of pixels and limited set of colors; 
• Supply files that are too low in resolution; 
• Submit graphics that are disproportionately large for the content.  
Color artwork  
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF), or 
MS Office files) and with the correct resolution. If, together with your accepted article, you submit 
usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear 
in color online (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations 
are reproduced in color in the printed version. For color reproduction in print, you will receive 
information regarding the costs from Elsevier after receipt of your accepted article. Please 
indicate your preference for color: in print or online only. Further information on the preparation of 
electronic artwork.  
Figure captions  
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A 
caption should comprise a brief title (not on the figure itself) and a description of the illustration. 
Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations 
used.  
Tables  
Please submit tables as editable text and not as images. Tables can be placed either next to the 
relevant text in the article, or on separate page(s) at the end. Number tables consecutively in 
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accordance with their appearance in the text and place any table notes below the table body. Be 
sparing in the use of tables and ensure that the data presented in them do not duplicate results 
described elsewhere in the article. Please avoid using vertical rules.  
Citation in text  
Please ensure that every reference cited in the text is also present in the reference list (and vice 
versa). Any references cited in the abstract must be given in full. Unpublished results and personal 
communications are not recommended in the reference list, but may be mentioned in the text. If 
these references are included in the reference list they should follow the standard reference style of 
the journal and should include a substitution of the publication date with either 'Unpublished results' 
or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been 
accepted for publication.  
Reference links  
Increased discoverability of research and high quality peer review are ensured by online links to the 
sources cited. In order to allow us to create links to abstracting and indexing services, such as 
Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. 
Please note that incorrect surnames, journal/book titles, publication year and pagination may 
prevent link creation. When copying references, please be careful as they may already contain 
errors. Use of the DOI is encouraged.  
A DOI can be used to cite and link to electronic articles where an article is in-press and full citation 
details are not yet known, but the article is available online. A DOI is guaranteed never to change, 
so you can use it as a permanent link to any electronic article. An example of a citation using DOI 
for an article not yet in an issue is: VanDecar J.C., Russo R.M., James D.E., Ambeh W.B., Franke 
M. (2003). Aseismic continuation of the Lesser Antilles slab beneath northeastern Venezuela. 
Journal of Geophysical Research, http://dx.doi.org/10.1029/2001JB000884i. Please note the format 
of such citations should be in the same style as all other references in the paper.  
Reference management software  
Most Elsevier journals have their reference template available in many of the most popular 
reference management software products. These include all products that support Citation Style 
Language styles, such as Mendeley and Zotero, as well as EndNote. Using the word processor plug-
ins from these products, authors only need to select the appropriate journal template when preparing 
their article, after which citations and bibliographies will be automatically formatted in the journal's 
style. If no template is yet available for this journal, please follow the format of the sample 
references and citations as shown in this Guide.  
Users of Mendeley Desktop can easily install the reference style for this journal by clicking the 
following link: 
http://open.mendeley.com/use-citation-style/colloids-and-surfaces-b-biointerfaces 
When preparing your manuscript, you will then be able to select this style using the Mendeley plug- 
ins for Microsoft Word or LibreOffice.  
Reference formatting  
There are no strict requirements on reference formatting at submission. References can be in any 
style or format as long as the style is consistent. Where applicable, author(s) name(s), journal 
title/book title, chapter title/article title, year of publication, volume number/book chapter and the 
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pagination must be present. Use of DOI is highly encouraged. The reference style used by the 
journal will be applied to the accepted article by Elsevier at the proof stage. Note that missing data 
will be highlighted at proof stage for the author to correct. If you do wish to format the references 
yourself they should be arranged according to the following examples:  
Reference Style  
1. All references made to publications in the text should be presented in a list of references 
following the text of the manuscript. The manuscript should be carefully checked to ensure that the 
information given in the text is exactly the same as that given in the reference list. 
References to the literature should be made according to the numerical system described below.  
2. In the text refer to the subject or to the author's name (without initial), followed by the reference 
number in square brackets.  
3. If reference is made in the text to publications written by more than two authors, the name of the 
first author should be used, followed by "et al.". Note that in the reference list the names of authors 
and co-authors should be given in full. 
4. References should be arranged in the order in which they appear in the text.  
5. Use the following system for arranging the references: 
(i) For journals 
N. Levy, N. Garti and S. Margdassi, Colloids Surfaces A: Physicochem. Eng. Aspects, 97 (1995) 
91. (ii) For monographs 
B.E. Conway, Ionic Hydration in Chemistry and Biophysics, Elsevier, Amsterdam, 1981. 
(iii) For edited books 
R.D. Thomas, in E. Buncel and J.R. Jones (Eds.), Isotopes in the Physical and Biomedical Sciences, 
Vol. 2, Elsevier, Amsterdam, 1991, Chapter 7. 
For conference proceedings, symposia etc. 
A.G. Marshall, in P.G. Kistemaker and N.M.M. Nibbering (Eds.), Advances in Mass Spectrometry, 
Proc. 12th International Mass Spectrometry Conference, Amsterdam, 26-30 August 1991, Elsevier, 
Amsterdam, 1992, p. 37. 
6. Abbreviations of journal titles should conform to those adopted by the Chemical Abstract Service 
(Bibliographic Guide for Editors and Authors, The American Chemical Society, Washington, DC, 
1974). If the correct abbreviation is not known, the title should be given in full. 
7. Reference to a personal communication should be followed by the year, e.g. A.N. Other, personal 
communication, 1989.  
Journal abbreviations source  
Journal names should be abbreviated according to the List of Title Word Abbreviations.  
Video  
Elsevier accepts video material and animation sequences to support and enhance your scientific 
research. Authors who have video or animation files that they wish to submit with their article are 
strongly encouraged to include links to these within the body of the article. This can be done in the 
same way as a figure or table by referring to the video or animation content and noting in the body 
text where it should be placed. All submitted files should be properly labeled so that they directly 
relate to the video file's content. In order to ensure that your video or animation material is directly 
usable, please provide the files in one of our recommended file formats with a preferred maximum 
size of 150 MB. Video and animation files supplied will be published online in the electronic 
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version of your article in Elsevier Web products, including ScienceDirect. Please supply 'stills' with 
your files: you can choose any frame from the video or animation or make a separate image. These 
will be used instead of standard icons and will personalize the link to your video data. For more 
detailed instructions please visit our video instruction pages. Note: since video and animation 
cannot be embedded in the print version of the journal, please provide text for both the electronic 
and the print version for the portions of the article that refer to this content.  
Supplementary material  
Supplementary material can support and enhance your scientific research. Supplementary files offer 
the author additional possibilities to publish supporting applications, high-resolution images, 
background datasets, sound clips and more. Please note that such items are published online exactly 
as they are submitted; there is no typesetting involved (supplementary data supplied as an Excel file 
or as a PowerPoint slide will appear as such online). Please submit the material together with the 
article and supply a concise and descriptive caption for each file. If you wish to make any changes 
to supplementary data during any stage of the process, then please make sure to provide an updated 
file, and do not annotate any corrections on a previous version. Please also make sure to switch off 
the 'Track Changes' option in any Microsoft Office files as these will appear in the published 
supplementary file(s). For more detailed instructions please visit our artwork instruction pages.  
Database linking  
Elsevier encourages authors to connect articles with external databases, giving readers access to 
relevant databases that help to build a better understanding of the described research. Please refer to 
relevant database identifiers using the following format in your article: Database: xxxx (e.g., TAIR: 
AT1G01020; CCDC: 734053; PDB: 1XFN). More information and a full list of supported 
databases.  
CONTENT INNOVATION  
AudioSlides  
The journal encourages authors to create an AudioSlides presentation with their published article. 
AudioSlides are brief, webinar-style presentations that are shown next to the online article on 
ScienceDirect. This gives authors the opportunity to summarize their research in their own words 
and to help readers understand what the paper is about. More information and examples are 
available. Authors of this journal will automatically receive an invitation e-mail to create an 
AudioSlides presentation after acceptance of their paper.  
3D molecular models  
You can enrich your online articles by providing 3D molecular models (optional) in PDB, PSE or 
MOL/MOL2 format, which will be visualized using the interactive viewer embedded within the 
article. Using the viewer, it will be possible to zoom into the model, rotate and pan the model, and 
change display settings. Submitted models will also be available for downloading from your online 
article on ScienceDirect. Each molecular model will have to be uploaded to the online submission 
system separately, via the '3D molecular models' submission category. More information.  
Interactive plots  
This journal enables you to show an Interactive Plot with your article by simply submitting a data 
file. Full instructions.  
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AFTER ACCEPTANCE  
Online proof correction  
Corresponding authors will receive an e-mail with a link to our online proofing system, allowing 
annotation and correction of proofs online. The environment is similar to MS Word: in addition to 
editing text, you can also comment on figures/tables and answer questions from the Copy Editor. 
Web-based proofing provides a faster and less error-prone process by allowing you to directly type 
your corrections, eliminating the potential introduction of errors.  
If preferred, you can still choose to annotate and upload your edits on the PDF version. All 
instructions for proofing will be given in the e-mail we send to authors, including alternative 
methods to the online version and PDF. 
We will do everything possible to get your article published quickly and accurately. Please use this 
proof only for checking the typesetting, editing, completeness and correctness of the text, tables and 
figures. Significant changes to the article as accepted for publication will only be considered at this 
stage with permission from the Editor. It is important to ensure that all corrections are sent back to 
us in one communication. Please check carefully before replying, as inclusion of any subsequent 
corrections cannot be guaranteed. Proofreading is solely your responsibility.  
Offprints  
The corresponding author will, at no cost, receive a customized Share Link providing 50 days free 
access to the final published version of the article on ScienceDirect. The Share Link can be used for 
sharing the article via any communication channel, including email and social media. For an extra 
charge, paper offprints can be ordered via the offprint order form which is sent once the article is 
accepted for publication. Both corresponding and co-authors may order offprints at any time via 
Elsevier's Webshop. Corresponding authors who have published their article open access do not 
receive a Share Link as their final published version of the article is available open access on 
ScienceDirect and can be shared through the article DOI link.  
AUTHOR INQUIRIES  
Visit the Elsevier Support Center to find the answers you need. Here you will find everything from 
Frequently Asked Questions to ways to get in touch. 
You can also check the status of your submitted article or find out when your accepted article will 
be published.  
 
